XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Noncontrolling Interests
Balance at Dec. 31, 2020 $ 103,806 $ 168 $ 1,012,932 $ 674 $ (909,968)  
Balance (in shares) at Dec. 31, 2020   168,170,000        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 1,171   1,171      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   2,621,000        
Stock-based compensation 5,333   5,333      
Other comprehensive loss (218)     (218)    
Net loss (17,457)       (17,457)  
Balance at Mar. 31, 2021 92,635 $ 168 1,019,436 456 (927,425)  
Balance (in shares) at Mar. 31, 2021   170,791,000        
Balance at Dec. 31, 2020 103,806 $ 168 1,012,932 674 (909,968)  
Balance (in shares) at Dec. 31, 2020   168,170,000        
Net loss (32,818)          
Balance at Jun. 30, 2021 84,237 $ 172 1,026,534 317 (942,786)  
Balance (in shares) at Jun. 30, 2021   171,572,000        
Balance at Mar. 31, 2021 92,635 $ 168 1,019,436 456 (927,425)  
Balance (in shares) at Mar. 31, 2021   170,791,000        
Issuance of common stock from exercise of stock options and vesting of restricted stock units 1,294 $ 4 1,290      
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)   781,000        
Stock-based compensation 5,808   5,808      
Other comprehensive loss (139)     (139)    
Net loss (15,361)       (15,361)  
Balance at Jun. 30, 2021 84,237 $ 172 1,026,534 317 (942,786)  
Balance (in shares) at Jun. 30, 2021   171,572,000        
Balance at Dec. 31, 2021 85,617 $ 174 1,048,936 (149) (964,342) $ 998
Balance (in shares) at Dec. 31, 2021   173,670,000        
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases 2,138 $ 3 2,135      
Issuance of common stock from exercise of stock options, vesting of restricted stock units, and ESPP purchases (in shares)   3,134,000        
Stock-based compensation 6,426   6,426      
Other comprehensive loss (1,486)     (1,486)    
Net loss (12,284)       (12,284)  
Balance at Mar. 31, 2022 80,411 $ 177 1,057,497 (1,635) (976,626) 998
Balance (in shares) at Mar. 31, 2022   176,804,000        
Balance at Dec. 31, 2021 85,617 $ 174 1,048,936 (149) (964,342) 998
Balance (in shares) at Dec. 31, 2021   173,670,000        
Net loss (20,679)          
Balance at Jun. 30, 2022 76,761 $ 177 1,062,760 (2,153) (985,015) 992
Balance (in shares) at Jun. 30, 2022   177,078        
Balance at Mar. 31, 2022 80,411 $ 177 1,057,497 (1,635) (976,626) 998
Balance (in shares) at Mar. 31, 2022   176,804,000        
Issuance of common stock from exercise of stock options and vesting of restricted stock units 256   256      
Issuance of common stock from exercise of stock options and vesting of restricted stock units (in shares)   274,000        
Stock-based compensation 5,007   5,007      
Other comprehensive loss (518)     (518)    
Net loss (8,395)       (8,389) (6)
Balance at Jun. 30, 2022 $ 76,761 $ 177 $ 1,062,760 $ (2,153) $ (985,015) $ 992
Balance (in shares) at Jun. 30, 2022   177,078